Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The most promising compounds, 39 and 40 (Figure 6), showed an IC 50 of 2.80 nM against DPP-4 catalytic activity, with 20 - 40-fold selectivity over the DPP-8 and DPP-9 isozymes
Non-pharmacological interventions FUSE Name: FUSE Manufacturer: Novo Nordisk and GE Healthcare Current stage: Phase II Takeaway: A non-pharmacological intervention could offer fewer side effects for patients
Step 5 : Compared with longer-acting agents such as atropine, tropicamide has a short duration of action, with mydriasis typically resolving within approximately 6 hours, allowing for faster recovery
Synaptic Neurexin complexes: a molecular code for the logic of neural circuits
